Fierce Biotech News & Reports
Fierce Biotech Layoff Tracker '24: Aurinia, Viracta & more. Nov 7, 2024 08:30am. Evotec attracts private equity buyout interest: report. Nov 11, 2024 06:17am. 23andMe shutters cancer drug research ...
A look at the R&D landscape in obesity, led by GLP-1s - Fierce …
Mar 19, 2024 · Viking Therapeutics’ dual GLP-1 and GIP agonist produced weight loss of up to 14.7% after 13 weeks of treatment in data released in February. The results were competitive to the Big Pharma ...
MedTech | Fierce Biotech
Oct 28, 2024 · Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot. Conor Hale Nov 12, 2024 1:45pm. Connect.
Regeneron to fill gaps in obesity, break ground in cell therapy
Feb 2, 2024 · Regeneron wants to fill the gaps in care with a combo approach from its pipeline, adding trevogrumab or garetosmab to semaglutide (Wegovy) to improve the quality of weight loss that patients ...
New AI drug discovery powerhouse Xaira rises with $1B in ...
Apr 24, 2024 · The company emerged Tuesday with $1 billion in committed funding—that’s billion with a B—incubated by Arch Venture Partners and Foresite Labs with none other than Marc Tessier-Lavigne, Ph.D ...
Bristol Myers pays $800M upfront for antibody-drug conjugate
Dec 12, 2023 · Bristol Myers Squibb has filled the antibody-drug conjugate (ADC) shaped hole in its pipeline by following the increasingly well-trodden path to China, handing SystImmune $800 million upfront for ...
Fierce Biotech Layoff Tracker 2024
Nov 7, 2024 · Last year, we tallied 187 total layoffs among biotech companies, a 57% jump compared to 119 in 2022. We hope that trend reverses itself in 2024. As always, if you know of a layoff occurring at a ...
Altos bursts out of stealth with $3B, a dream team C-suite and a …
Jan 19, 2022 · Altos Labs just redefined big. RELATED: Barron quits GSK to take CEO post at $3B biotech startup The team will use $3 billion in capital committed by investors including Arch Venture Partners to ...
Fierce Biotech Fundraising Tracker 2024
1 day ago · Fierce Biotech Fundraising Tracker '24: TRexBio roars with $84M series B; Alentis adds on $181M for ADCs. A new year means a new Fierce Biotech Fundraising Tracker to record all the venture ...
Regeneron plans $1.8B upgrade at Tarrytown campus ...
Jul 16, 2021 · The Empire State's biggest biotech Regeneron Pharmaceuticals is plotting a hefty investment to beef up R&D in Tarrytown. | Regeneron laid plans for a six-year, $1.8 billion expansion at its ...